Klotho Neurosciences Inc - KLTO Company profit before taxes, interest and amortization
Klotho Neurosciences Inc (KLTO) relies on the high scalability of intellectual capital within the field of CNS anti-aging. Operating cash flow before depreciation clearly demonstrates cash flow dynamics, where the 0.00 level records fresh values. A breakthrough R&D pipeline for the treatment of Alzheimer's and ALS complements the image of a scientific brand that is actively implementing innovations in gerontology and brain health.
Summary analytical data breakdowns for Klotho Neurosciences (KLTO)
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Klotho Neurosciences Inc|KLTO - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio ANEW Medical|KLTO - Company Aggregate Debts|Debts to Book Value Klotho Neurosciences|KLTO - Company Long-Term Liabilities|Company Short-Term Debts Klotho Neurosciences|Intermediate Coverage Ratio anewmeds.com
- earnings and market ratios statistics:
KLTO - Company Net Income|Expected Net Profit Klotho Neurosciences Inc|KLTO - Price to Earnings Ratio|Market Cap to Projected Earnings ANEW Medical|KLTO - PEG Multiple|Enterprise Value to EBITDA Ratio Klotho Neurosciences|KLTO - Operating profit EBITDA|Net earnings per share for the last four quarters Klotho Neurosciences|KLTO - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months anewmeds.com|KLTO - Earnings per share growth in current year|Projected earnings per share growth rate for next year Klotho Neurosciences Inc
Summary company analytics:Klotho Neurosciences Inc
For Klotho Neurosciences Inc (KLTO), whose operations are limited to laboratory research without industrial production, EBITDA serves as an indicator of actual cash flow. This metric excludes GAAP accounting adjustments to calculate the net volume of operating cash, allowing investors to objectively assess capital financial stability and avoid purchasing an overvalued asset at an early stage of development.
Competitor analysis for Klotho Neurosciences Inc
Biogen Idec (BIIB) - Profit before interest, taxes and amortization|NBIX: Operating profit before deduction of amortization|regencellbioscience.com - Company profit before taxes, interest and amortization|AXSM: Operating profit EBITDA|ACADIA Pharma - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Xenon Pharmaceuticals Inc|Profit before interest, taxes and amortization Viking Therapeutics Corp VKTX|Operating profit before deduction of amortization SUPN (Supernus Pharmaceuticals)|CPRX (catalystpharma.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Denali Therapeutics Inc. DNLI|HRMY: Operating profit before amortization|Biohaven Pharmaceutical - Operating profit EBITDA|Profit before interest, taxes and amortization Amylyx Corp|TRVI (Trevi Therapeutics) - Operating profit before deduction of amortization|praxismedicines.com (PRAX) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Anavex Life Sciences Corp.|CBLL: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Prothena Corp (PRTA)|ALEC - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Annexon, Inc. ANNX|Operating income before deduction of amortization Omeros Corp (OMER)|Neurogene - Operating profit EBITDA|AC Immune S.A. (ACIU) - Operating profit before deduction of amortization|VYGR: Operating profit EBITDA|NMRA - Operating income before deduction of amortization|SCLX (Scilex Holding Company) - Operating profit EBITDA|Profit before interest, taxes and amortization tevogen.com TVGN|Profit before payment of interest, taxes and amortization Alpha Cognition (ACOG)|Cognition Therapeutics Inc. - Operating profit before amortization|Operating profit EBITDA IKT (Inhibikase)|SAVA - Operating profit before deduction of amortization|Assertio Therapeutics - Operating profit EBITDA|Profit before interest, taxes and amortization Coya Therapeutics, Inc.|vistagen.com (VTGN) - Profit before payment of interest, taxes and amortization|OVID - Operating income before deduction of amortization|Operating profit before deduction of amortization ABOS|CRVO: Income before deduction of interest, taxes and amortization|Operating profit EBITDA ATHE|Operating income before deduction of amortization clene.com|Profit before payment of interest, taxes and amortization PepGen PEPG|JUNS: Operating profit before amortization|Relmada - Operating profit EBITDA|Annovis Bio Corporation (ANVS) - Operating profit before deduction of amortization|gracetx.com (GRCE) - Profit before payment of interest, taxes and amortization|fireflyneuro.com (AIFF) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization NeuroSense Therapeutics Ltd|Profit before payment of interest, taxes and amortization RVPH|Operating profit before deduction of amortization MTVA (MetaVia Inc)|Company profit before taxes, interest and amortization NRXS|Profit before payment of interest, taxes and amortization Helius Medical Technologies HSDT|Passage Bio Inc. (PASG) - Profit before interest, taxes and amortization|NEUP - Profit before payment of interest, taxes and amortization|NERV (Minerva Neurosciences Inc) - Operating profit before amortization|ATHA: Operating profit EBITDA|Profit before interest, taxes and amortization Addex (ADXN)|Operating profit before deduction of amortization ALZN|Operating profit EBITDA Cyclerion|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Cortigent CRGT|Avenue Therapeutics Inc (ATXI) - Profit before interest, taxes and amortization|BCLI - Profit before payment of interest, taxes and amortization|CARA - Operating profit EBITDA|Chromocell Therapeutics Corp. (CHRO) - Profit before payment of interest, taxes and amortization|ELYM (Eliem Therapeutics Inc.) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Intra-Cellular Therapies Inc.|Profit before interest, taxes and amortization Longboard LBPH|Operating profit before deduction of amortization MRNS (Marinus Pharmaceuticals)|Company profit before taxes, interest and amortization NKGN|Operating profit EBITDA NRBO (NeuroBo Pharmaceuticals, Inc.)|Income before deduction of interest, taxes and amortization SAGE|SNPX - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Trevena Inc|VIGL (vigilneuro.com) - Operating profit before deduction of amortization|anewmeds.com - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Cerevel Therapeutics, Inc.
